The effect of clomipramine on wake/sleep and orexinergic expression in rats

Journal of Psychopharmacology

Volumn 23, Issue 5, 2009, Pages 559-566

  Feng, P ^a,b,c   Hu, Y ^b   Li, D ^a   Vurbic, D ^b   Fan, H ^b   Wang, S ^a   Strohl, K P ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Antidepressant; Clomipramine; Orexin; Orexin receptors; Rats; Sleep; Wake

Indexed keywords

CLOMIPRAMINE; MESSENGER RNA; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN A; OREXIN B; PREPROOREXIN; PROTEIN PRECURSOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFECT; FRONTAL CORTEX; GENE EXPRESSION; HYPOTHALAMUS; MALE; NONHUMAN; NONREM SLEEP; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RAT; RECEPTOR GENE; REM SLEEP; SLEEP TIME; SLEEP WAKING CYCLE;

ANIMALS; BRAIN; CLOMIPRAMINE; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEUROPEPTIDES; POLYMERASE CHAIN REACTION; POLYSOMNOGRAPHY; RADIOIMMUNOASSAY; RATS; RATS, LONG-EVANS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS; SLEEP; WAKEFULNESS;

EID: 67449152739     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108089606     Document Type: Article

References (54)

1. Allard JS., Tizabi Y., Shaffery JP., Trouth CO., Manaye K., (2004) Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression. Neuropeptides 38: 311-315. (Pubitemid 39298731)
2. Andrade LA., Lima JG., Tufik S., Bertolucci PH., Carlini EA., (1987) Rem sleep deprivation in an experimental model of Parkinson™s disease. Arq Neuropsiquiatr 45: 217-223.
3. Auerbach SB., Lundberg JF., Hjorth S., (1995) Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration. Neuropharmacology 34: 89-96.
4. Asakura W., Matsumoto K., Ohta H., Watanabe H., (1993) Effect of alpha 2-adrenergic drugs on REM sleep deprivation-induced increase in swimming activity. Pharmacol Biochem Behav 46: 111-115.
5. Asakura W., Matsumoto K., Ohta H., Watanabe H., (1994) Involvement of dopamine D2 receptor mechanism in the REM sleep deprivation-induced increase in swimming activity in the forced swimming test. Pharmacol Biochem Behav 48: 43-46.
6. Blanco-Centurion CA., Shiromani PJ., (2006) Beneficial effects of regular exercise on sleep in old F344 rats. Neurobiol Aging 27: 1859-1869. (Pubitemid 44572583)
7. Brown RE., Sergeeva OA., Eriksson KS., Haas HL., (2002) Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J Neurosci 22: 8850-8859. (Pubitemid 35379054)
8. Brundin L., Bjorkqvist M., Petersen A., Traskman-Bendz L., (2007a) Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. Eur Neuropsychopharmacol 17: 573-579. (Pubitemid 47068932)
9. Brundin L., Petersen A., Bjorkqvist M., Traskman-Bendz L., (2007b) Orexin and psychiatric symptoms in suicide attempters. J Affect Disord 100: 259-263. (Pubitemid 46818444)
10. Crews FT., Smith CB., (1980) Potentiation of responses to adrenergic nerve stimulation in isolated rat atria during chronic tricyclic antidepressant administration. J Pharmacol Exp Ther 215: 143-149. (Pubitemid 11102266)
11. De Lecea L., Kilduff TS., Peyron C., Gao X., Foye PE., Danielson PE., (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 95: 322-327. (Pubitemid 28103952)
12. Dunn AL., Trivedi MH., Kampert JB., Clark CG., Chambliss HO., (2005) Exercise treatment for depression: efficacy and dose response. Am J Prev Med 28: 1-8. (Pubitemid 40051319)
13. Espana RA., Baldo BA., Kelley AE., Berridge CW., (2001) Wake-promoting and sleep-suppressing actions of hypocretin (orexin). basal forebrain sites of action. Neuroscience 106: 699-715. (Pubitemid 33000176)
14. Feng P., Ma Y., (2002) Clomipramine suppresses postnatal REM sleep without increasing wakefulness: implications for the production of depressive behaviors. Sleep 25: 177-184. (Pubitemid 34193578)
15. Feng P., Ma Y., (2003) Instrumental REM sleep deprivation in neonates leads to adult depression-like behaviors in rats. Sleep 26: 990-996. (Pubitemid 39619760)
16. Feng P., Vurbic D., Wu Z., Hu Y., Strohl KP., (2008) Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine. J Psychopharmacol (in press. doi:10.1177/0269881107082899).
17. Feng P., Vurbic D., Wu Z., Strohl KP., (2007) Brain orexins and wake regulation in rats exposed to maternal deprivation. Brain Res 1154C: 163-172. (Pubitemid 46856334)
18. Goodwin RD., (2003) Association between physical activity and mental disorders among adults in the United States. Prev Med 36: 698-703. (Pubitemid 36555550)
19. Henderson LP., (1983) The role of 5-hydroxytryptamine as a transmitter between identified leech neurones in culture. J Physiol 339: 309-324.
20. Judd FK., Chua P., Lynch C., Norman T., (1991) Fenfluramine augmentation of clomipramine treatment of obsessive compulsive disorder. Aust N Z J Psychiatry 25: 412-414.
21. Kastin AJ., Akerstrom V., (1999) Orexin A but not orexin B rapidly enters brain from blood by simple diffusion. J Pharmacol Exp Ther 289: 219-223. (Pubitemid 29156032)
22. Kinney GG., Vogel GW., Feng P., (1997) Decreased dorsal raphe nucleus neuronal activity in adult chloral hydrate anesthetized rats following neonatal clomipramine treatment: implications for endogenous depression. Brain Res 756: 68-75. (Pubitemid 27241609)
23. Kotz CM., Wang C., Teske JA., Thorpe AJ., Novak CM., Kiwaki K., (2006) Orexin A mediation of time spent moving in rats: neural mechanisms. Neuroscience 142: 29-36. (Pubitemid 44354985)
24. Li Y., van den Pol AN., (2005) Direct and indirect inhibition by catecholamines of hypocretin/orexin neurons. J Neurosci 25: 173-183. (Pubitemid 40110778)
25. Liu RJ., van den Pol AN., Aghajanian GK., (2002) Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J Neurosci 22: 9453-9464. (Pubitemid 35356188)
26. Martins PJ., D™Almeida V., Pedrazzoli M., Lin L., Mignot E., Tufik S., (2004) Increased hypocretin-1 (orexin-a) levels in cerebrospinal fluid of rats after short-term forced activity. Regul Pept 117: 155-158. (Pubitemid 38121649)
27. Maudhuit C., Hamon M., Adrien J., (1995) Electrophysiological activity of raphe dorsalis serotoninergic neurones in a possible model of endogenous depression. Neuroreport 6: 681-684.
28. Mignot E., Taheri S., Nishino S., (2002) Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat Neurosci 5 (Suppl.). 1071-1075. (Pubitemid 35247202)
29. Mirmiran M., Scholtens J., van de Poll NE., Uylings HB., van der Gugten J., Boer GJ., (1983) Effects of experimental suppression of active (REM) sleep during early development upon adult brain and behavior in the rat. Brain Res 283: 277-286.
30. Mirmiran M., van de Poll NE., Corner MA., van Oyen HG., Bour HL., (1981) Suppression of active sleep by chronic treatment with chlorimipramine during early postnatal development: effects upon adult sleep and behavior in the rat. Brain Res 204: 129-146. (Pubitemid 11247494)
31. Mitsuma T., Hirooka Y., Kayma M., Mori Y., Yokoi Y., Izumi M., (2000a) Radioimmunoassay for orexin A. Life Sci 66: 897 - 904. (Pubitemid 30084476)
32. Mitsuma T., Hirooka Y., Kayama M., Mori Y., Yokoi Y., Rhue N., (2000b) Radioimmunoassay for hypocretin-2. Endocr Regul 34: 23-27.
33. Morgan K., (2003) Daytime activity and risk factors for late-life insomnia. J Sleep Res 12: 231-238. (Pubitemid 37083021)
34. Muraki Y., Yamanaka A., Tsujino N., Kilduff TS., Goto K., Sakurai T., (2004) Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor. J Neurosci 24: 7159-7166. (Pubitemid 39096381)
35. Ogren SO., Cott JM., Hall H., (1981) Sedative/anxiolytic effects of antidepressants in animals. Acta Psychiatr Scand 290 (Suppl.). 277-288. (Pubitemid 11156120)
36. Persson SA., (1980) The effects of chlorimipramine and protriptyline on tube running activity in mice. Pharmacol Biochem Behav 12: 255-258. (Pubitemid 10110138)
37. Peyron C., Tighe DK., van den Pol AN., de Lecea L., Heller HC., Sutcliffe JG., (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18: 9996-10015. (Pubitemid 28543775)
38. Randeva HS., Karteris E., Grammatopoulos D., Hillhouse EW., (2001) Expression of orexin-A and functional orexin type 2 receptors in the human adult adrenals: implications for adrenal function and energy homeostasis. J Clin Endocrinol Metab 86: 4808 - 4813. (Pubitemid 33020524)
39. Riemann D., Berger M., Voderholzer U., (2001) Sleep and depression-results from psychobiological studies: an overview. Biol Psychol 57: 67-103. (Pubitemid 32651895)
40. Romero L., Hervas I., Artigas F., (1996) The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. Neurosci Lett 219: 123-126. (Pubitemid 26396330)
41. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli RM., Tanaka H., (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 1-696.
42. Sakurai T., Moriguchi T., Furuya K., Kajiwara N., Nakamura T., Yanagisawa M., (1999) Structure and function of human prepro-orexin gene. J Biol Chem 274: 17771-17776.
43. Salomon RM., Ripley B., Kennedy JS., Johnson B., Schmidt D., Zeitzer JM., (2003) Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol Psychiatry 54: 96-104. (Pubitemid 36859768)
44. Sangdee C., Franz DN., (1979) Enhancement of central norepinephrine and 5-hydroxytryptamine transmission by tricyclic antidepressants. A comparison. Psychopharmacology 62: 9-16. (Pubitemid 10226228)
45. Silveyra P., Catalano PN., Lux-Lantos V., Libertun C., (2007) Impact of proestrous milieu on expression of orexin receptors and prepro-orexin in rat hypothalamus and hypophysis: actions of cetrorelix and nembutal. Am J Physiol Endocrinol Metab 292: E820-E828.
46. Sutcliffe JG., de Lecea L., (2002) The hypocretins: setting the arousal threshold. Nat Rev Neurosci 3: 339-349. (Pubitemid 135706631)
47. Thakkar MM., Ramesh V., Strecker RE., McCarley RW., (2001) Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats. Arch Ital Biol 139: 313-328. (Pubitemid 32274943)
48. Torterolo P., Yamuy J., Sampogna S., Morales FR., Chase MH., (2003) Hypocretinergic neurons are primarily involved in activation of the somatomotor system. Sleep 26: 25-28.
49. Trivedi P., Yu H., MacNeil DJ., Van der Ploeg LH., Guan XM., (1998) Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 438: 71-75. (Pubitemid 28517837)
50. Vogel GW., (1999) REM sleep deprivation and behavioral changes. In: BN Mallick., S Inou., (eds). Rapid Eye Movement Sleep. London: Narasa Publishing House, pp. 355-366.
51. Vogel G., Neill D., Hagler M., Kors D., (1990a) A new animal model of endogenous depression: a summary of present findings. Neurosci Biobehav Rev 14: 85-91. (Pubitemid 20115617)
52. Vogel GW., Buffenstein A., Minter K., Hennessey A., (1990b) Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Rev 14: 49-63. (Pubitemid 20115612)
53. Xi MC., Morales FR., Chase MH., (2001) Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Res 901: 259-264. (Pubitemid 32718830)
54. Zhang JH., Sampogna S., Morales FR., Chase MH., (2001) Orexin (hypocretin)-like immunoreactivity in the cat hypothalamus: a light and electron microscopic study. Sleep 24: 67-76. (Pubitemid 32096736)